Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3

被引:60
作者
Testard, Alexandra
Loge, Cedric
Leger, Benoit
Robert, Jean-Michel
Lozach, Olivier
Blairvacq, Melina
Meijer, Laurent
Thiery, Valerie
Besson, Thierry
机构
[1] Univ La Rochelle, UFR Sci Fondamentales & Sci Ingn, FRE CNRS 2766, Lab Biotechnol & Chim Bioorgan, F-17042 La Rochelle, France
[2] Univ Nantes, Nantes Atlantique Univ, Dept Pharmacochim, BioCiT EA 1155,UFR Sci Pharmaceut, F-44000 Nantes, France
[3] Biol Stn, Cell Cycle Grp, UMR7150, F-29682 Roscoff, France
[4] Biol Stn, UPS2682, F-29682 Roscoff, France
关键词
glycogen synthase kinase-3 inhibitors; quinazolines; microwave-assisted chemistry; molecular modeling;
D O I
10.1016/j.bmcl.2006.04.006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In an effort to identify new protein kinase inhibitors with increased potency and selectivity, we have developed the microwave-assisted synthesis of thiazolo[5,4-f]quinazolin-9-ones. The effects of eighteen derivatives on CDK1/cyclin B, CDK5/p25, and GSK-3 were investigated. Several turned out to inhibit GSK-3 in the micromolar range. Molecular modeling studies suggest that the most selective GSK-3 inhibitors 7a-d bind into the ATP-binding site through a key hydrogen bond interaction with Val135 and target the specific hydrophobic backpocket of the enzyme. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3419 / 3423
页数:5
相关论文
共 25 条
[1]   Efficient synthesis of thiazoloquinazolinone derivatives [J].
Alexandre, FR ;
Berecibar, A ;
Wrigglesworth, R ;
Besson, T .
TETRAHEDRON LETTERS, 2003, 44 (24) :4455-4458
[2]   SYNTHESIS AND REACTIONS OF 4,5-DICHLORO-1,2,3-DITHIAZOLIUM CHLORIDE [J].
APPEL, R ;
JANSSEN, H ;
SIRAY, M ;
KNOCH, F .
CHEMISCHE BERICHTE-RECUEIL, 1985, 118 (04) :1632-1643
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]   Multistep synthesis of thiazoloquinazolines under microwave irradiation in solution [J].
Besson, T ;
Guillard, J ;
Rees, CW .
TETRAHEDRON LETTERS, 2000, 41 (07) :1027-1030
[5]  
BESSON T, 2005, HETEROCYCLIC CHEM US, pCH3
[6]   Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418 [J].
Bhat, R ;
Xue, YF ;
Berg, S ;
Hellberg, S ;
Ormö, M ;
Nilsson, Y ;
Radesäter, AC ;
Jerning, E ;
Markgren, PO ;
Borgegård, T ;
Nylöf, M ;
Giménez-Cassina, A ;
Hernández, F ;
Lucas, JJ ;
Díaz-Nido, J ;
Avila, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :45937-45945
[7]   Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition [J].
Borgne, A ;
Meijer, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) :27847-27854
[8]   VALIDATION OF THE GENERAL-PURPOSE TRIPOS 5.2 FORCE-FIELD [J].
CLARK, M ;
CRAMER, RD ;
VANOPDENBOSCH, N .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1989, 10 (08) :982-1012
[9]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315
[10]   Inhibition of cyclin-dependent kinases by purine analogues - Crystal structure of human cdk2 complexed with roscovitine [J].
DeAzevedo, WF ;
Leclerc, S ;
Meijer, L ;
Havlicek, L ;
Strnad, M ;
Kim, SH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :518-526